Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Myelodysplastic syndromes.

    ... have been achieved in understanding and treating myelodysplastic syndromes (MDS) in the past decade. For the first time, three drugs were ...

    Research Article last updated 06/20/2013 - 10:37am.

  2. Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative

    ... Challenges exist in the diagnosis and treatment of myelodysplastic syndromes (MDS). Early clinical presentation can be subtle, accurate ...

    Research Article last updated 02/08/2013 - 7:53am.

  3. Methylation of Promoters of microRNAs and their Host Genes in Myelodysplastic Syndromes.

    ... ABSTRACT Myelodysplastic syndromes (MDS) are a group of hematopoietic malignancies characterized by ...

    Research Article last updated 05/14/2013 - 2:58pm.

  4. Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes

    ... Increased autoantibody reactivity in plasma from Myelodysplastic Syndromes (MDS) patients may provide novel disease signatures, and possible ...

    Research Article last updated 11/26/2013 - 12:27pm.

  5. Myelodysplastic syndromes, version 2.2015

    ... The NCCN Guidelines for Myelodysplastic Syndromes (MDS) comprise a heterogeneous group of myeloid disorders with a ...

    Research Article last updated 04/08/2015 - 2:15pm.

  6. Established and novel agents for myelodysplastic syndromes

    ... The myelodysplastic syndromes (MDS) are the most commonly diagnosed myeloid malignancy, with ...

    Research Article last updated 03/03/2015 - 1:10pm.

  7. Myelodysplastic syndromes

    ... The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic ...

    Research Article last updated 08/06/2013 - 12:31pm.

  8. Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes

    ... The treatment of patients with myelodysplastic syndromes (MDS) begins with assessment of karyotype and risk. ...

    Research Article last updated 12/08/2015 - 1:06pm.

  9. Foundation Update - June 2016

    ... understanding and treatment of aplastic anemia , myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH). ...

    Article last updated 10/09/2017 - 2:54pm.

  10. Foundation Update - June 2017

    ... understanding and treatment of aplastic anemia , myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH). The ...

    Article last updated 10/09/2017 - 2:42pm.